Iveric Bio   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Princeton NJ United States (2007)

Organization Overview

First Clinical Trial
2007
NCT00569140
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

IVERIC bio, Inc. | Ophthotech Corporation